MAVENCLAD Trademark

Trademark Overview

On Wednesday, January 18, 2017, a trademark application was filed for MAVENCLAD with the United States Patent and Trademark Office. The USPTO has given the MAVENCLAD trademark a serial number of 79202778. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, March 26, 2024. This trademark is owned by Merck KGaA. The MAVENCLAD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceutical preparations for the treatment of inflammatory and immunological diseases and disorders
mavenclad

General Information

Serial Number79202778
Word MarkMAVENCLAD
Filing DateWednesday, January 18, 2017
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, March 26, 2024
Registration Number5253420
Registration DateTuesday, August 1, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2017

Trademark Statements

Goods and ServicesPharmaceutical products, namely, pharmaceutical preparations for the treatment of inflammatory and immunological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 10, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Tuesday, March 26, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Tuesday, March 26, 2024REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Monday, March 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, July 13, 2023TEAS SECTION 71 & 15 RECEIVED
Monday, August 1, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 8, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, November 21, 2017FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, November 21, 2017FINAL DISPOSITION PROCESSED
Wednesday, November 1, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 1, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, May 16, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 15, 2017REFUSAL PROCESSED BY IB
Tuesday, April 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 3, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 3, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 3, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 3, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 30, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 30, 2017REFUSAL PROCESSED BY MPU
Wednesday, March 29, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 28, 2017NON-FINAL ACTION WRITTEN
Friday, March 24, 2017ASSIGNED TO EXAMINER
Tuesday, March 14, 2017APPLICATION FILING RECEIPT MAILED
Friday, March 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 9, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

mavenclad pharmaceutical immunological diseases disorders inflammatory treatment products namely preparations